Skip to main content

Table 3 Facilitators to implementing the results of the Magpie Trial by country*

From: Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia

Facilitator Number of countries from which at least one representative gave a response
  Low and lower-middle income countries
(n = 13#)
Upper-middle income countries
(n = 3#)
High-income countries
(n = 8#)
Total
Channels to public authorities 6 2 2 10
Development/use of clinical practice guidelines 4 1 4 9
Publications in medical journals 5 0 2 7
Resources 4 1 1 6
International organisations 4 1 0 5
Professional organisations 2 3 3 8
Licensing and availability of magnesium sulphate 3 0 3 6
  1. * 29 respondents provided illegible responses to this question.
  2. # Total number of countries in this group.